Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.

Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.

<h4>Background</h4>Direct oral anticoagulants (DOACs) have comparable efficacy with low-molecular-weight heparin (LMWH) for the treatment of cancer-associated venous thromboembolism (VTE). Whether there is a mortality benefit of DOACs compared with warfarin in the management of VTE in ca...

Full description

Bibliographic Details
Main Authors: Adeel M Khan, Thita Chiasakul, Robert Redd, Rushad Patell, Ellen P McCarthy, Donna Neuberg, Jeffrey I Zwicker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-05-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004012

Internet

https://doi.org/10.1371/journal.pmed.1004012

Similar Items